Press Releases Allakos Inc.

Equities

ALLK

US01671P1003

Market Closed - Nasdaq Other stock markets 02:00:00 04/05/2024 am IST			5-day change	1st Jan Change
1.16 ^USD	+5.45%		+13.73%	-57.51%

15/03	North American Morning Briefing : Inflation Worries Continue to Weigh on Mood	DJ
14/03	Allakos Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	CI

Press Releases

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Allakos Provides Business Update and Reports Fourth Quarter and Full Year 2023 Financial Results	15/03	GL
Allakos Provides Business Update and Reports Fourth Quarter and Full Year 2023 Financial Results	15/03	AQ
Allakos Presents Preclinical Data Highlighting Inhibition of MRGPRX2-Mediated Mast Cell Activation with AK006 at AAAAI 2024	26/02	GL
Allakos Presents Preclinical Data Highlighting Inhibition of MRGPRX2-Mediated Mast Cell Activation with AK006 at AAAAI 2024	26/02	AQ
Allakos Announces Publication Highlighting AK006 Mast Cell Inhibition	12/02	GL
Allakos Announces Publication Highlighting AK006 Mast Cell Inhibition	12/02	AQ
Pomerantz Law Firm Investigates Claims on Behalf of Investors of Allakos Inc. - ALLK	08/02	PR
Pomerantz Law Firm Investigates Claims on Behalf of Investors of Allakos Inc. - ALLK	31/01	PR
Pomerantz Law Firm Investigates Claims on Behalf of Investors of Allakos Inc. - ALLK	23/01	PR
Allakos Announces a Restructuring to Focus on Development of AK006	16/01	GL
Allakos Announces Phase 2 Lirentelimab Trials in Atopic Dermatitis and Chronic Spontaneous Urticaria Did Not Meet Their Primary Endpoints	16/01	GL
Allakos Announces a Restructuring to Focus on Development of AK006	16/01	AQ
Allakos Announces Phase 2 Lirentelimab Trials in Atopic Dermatitis and Chronic Spontaneous Urticaria Did Not Meet Their Primary Endpoints	16/01	AQ
Allakos Provides Business Update and Reports Third Quarter 2023 Financial Results	14/11	GL
Allakos Provides Business Update and Reports Third Quarter 2023 Financial Results	14/11	AQ
Allakos Appoints Neil Graham to its Board of Directors	31/23/31	GL
Allakos Provides Business Update and Reports Second Quarter 2023 Financial Results	10/23/10	GL
Allakos Provides Business Update and Reports Second Quarter 2023 Financial Results	10/23/10	AQ
Allakos : Appoints Rand Sutherland and Dolca Thomas to its Board of Directors - Form 8-K	03/23/03	PU
Allakos Appoints Rand Sutherland and Dolca Thomas to its Board of Directors	03/23/03	GL

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Press Releases Allakos Inc.

Equities

ALLK

US01671P1003

Press Releases

Filters